Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...
Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order ...
The FDA resolved the shortage of Eli Lilly's tirzepatide, but may revisit allowing compounding pharmacies to make copies, ...
As for why it’s not approved for weight loss in the UK, Dr Kayat added: “It works by helping to regulate your appetite and ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
Dubbed the “King Kong” of weight loss jabs, Mounjaro, the brand name for tirzepatide, is a weekly injection licensed to treat type 2 diabetes on the NHS. Trials have shown some users can lose ...
Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...
Drugs like Ozempic and Wegovy may provide a surprising, life-saving benefit for the youngest patients taking these diabetes and weight loss medications.